Identification of secreted proteins as novel antigenic vaccine candidates of Haemophilus parasuis serovar 5

Vaccine

Volumn 33, Issue 14, 2015, Pages 1695-1701

  Li, Miao ^a,b,c,d   Song, Shuai ^b,c,d   Yang, Dongxia ^b,c,d   Li, Chunling ^b,c,d   Li, Guoqing ^a  

^a SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF ANIMAL SCIENCE   (China)

^c Guangdong Common Lab of Veterinary Public Health   (China)

^d Guangdong Key Laboratory of Animal Epidemic Diseases Prevention   (China)

Author keywords

Haemophilus parasuis; Immune responses; Protection; Secreted proteins; Vaccine candidate

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; HAEMOPHILUS VACCINE; INTERLEUKIN 2; INTERLEUKIN 4; PROTEIN GCP; PROTEIN HAPS 0017; PROTEIN HSDS; PROTEIN NDK; PROTEIN PFLA; PROTEIN RNFC; RECOMBINANT PROTEIN; SECRETORY PROTEIN; SUBUNIT VACCINE; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOINFORMATICS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; ESCHERICHIA COLI; FEMALE; GLASSER DISEASE; HAEMOPHILUS PARASUIS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTYPE; SPLEEN CELL; SUPERNATANT; SWINE DISEASE; TH1 CELL; ANIMAL; BIOLOGY; BLOOD; CELL CULTURE; CHEMISTRY; DISEASE MODEL; GENETICS; HUMORAL IMMUNITY; IMMUNOLOGY; ISOLATION AND PURIFICATION; PIG; SECRETION (PROCESS); SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; HAEMOPHILUS PARASUIS; HAEMOPHILUS VACCINES; IMMUNITY, HUMORAL; INJECTIONS, SUBCUTANEOUS; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-4; MICE; RECOMBINANT PROTEINS; SEROGROUP; SWINE; VACCINES, SUBUNIT;

EID: 84925244558     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.02.023     Document Type: Article

References (28)

1. Oliveira S., Pijoan C. Haemophilus parasuis: new trends on diagnosis, epidemiology and control. Vet Microbiol 2004, 99(1):1-12.
2. Kielstein P., Rapp-Gabrielson V.J. Designation of 15 serovars of Haemophilus parasuis on the basis of immunodiffusion using heat-stable antigen extracts. J Clin. Microbiol 1992, 30(4):862-865.
3. Oliveira S., Blaekall P.J., Pojoan C. Characterization of the diversity of Haemophilus parasuis field isolates by use of serotyping and genotyping. Am J Vet Res 2003, 64(4):435-442.
4. Tadjine M., Mittal K.R., Bourdon S., Gottschalk M. Development of a new serological test for serotyping Haemophilus parasuis isolates and determination of their prevalence in North America. J Clin Microbiol 2004, 42:839-840.
5. Cai X., Chen H., Blackall P.J., Yin Z., Wang L., Liu Z., et al. Serological characterization of Haemophilus parasuis isolates from China. Vet Microbiol 2005, 111(3-4):231-236.
6. Martín de la Fuente A.J., Gutiérrez Martín C.B., Pérez Martínez C., García Iglesias M.J., Tejerina F., Rodríguez Ferri E.F. Effect of different vaccine formulations on the development of Glässer's disease induced in pigs by experimental Haemophilus parasuis infection. J Comp Pathol 2009, 140(2-3):169-176.
7. Liu L., Cheng G., Wang C., Pan X., Cong Y., Pan Q., et al. Identification and experimental verification of protective antigens against Streptococcus suis serotype 2 based on genome sequence analysis. Curr Microbiol 2009, 58(1):11-17.
8. Schubert-Unkmeir A., Christodoulides M. Genome-based bacterial vaccines: current state and future outlook. BioDrugs 2013, 27(5):419-430.
9. Etz H., Minh D.B., Henics T., Dryla A., Winkler B., Triska C., et al. Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc Natl Acad Sci USA 2002, 99(10):6573-6578.
10. Yang H.L., Zhu Y.Z., Qin J.H., He P., Jiang X.C., et al. In silico and microarray-based genomic approaches to identifying potential vaccine candidates against Leptospira interrogans. BMC Genomics 2006, 7:293.
11. He P., Sheng Y.Y., Shi Y.Z., Jiang X.G., Qin J.H., Zhang Z.M., et al. Genetic diversity among major endemic strains of Leptospira interrogans in China. BMC Genomics 2007, 8:204.
12. Huntley J.F., Conley P.G., Hagman K.E., Norgard M.V. Characterization of Francisella tularensis outer membrane proteins. J Bacteriol 2007, 189(2):561-574.
13. Grandi G. Bacterial surface proteins and vaccines. F1000 Biol Rep 2010, 2:36.
14. Zhang B., Tang C., Yang F.L., Yue H. Molecular cloning, sequencing and expression of the outer membrane protein A gene from Haemophilus parasuis. Vet Microbiol 2009, 136(3-4):408-410.
15. Zhou M., Guo Y., Zhao J., Hu Q., Hu Y., Zhang A., et al. Identification and characterization of novel immunogenic outer membrane proteins of Haemophilus parasuis serovar 5. Vaccine 2009, 27(38):5271-5277.
16. Fu S., Zhang M., Xu J., Ou J., Wang Y., Liu H., et al. Immunogenicity and protective efficacy of recombinant Haemophilus parasuis SH0165 putative outer membrane proteins. Vaccine 2013, 31(2):347-353.
17. Yuan F., Fu S., Hu J., Li J., Chang H., Hu L., et al. Evaluation of recombinant proteins of Haemophilus parasuis strain SH0165 as vaccine candidates in a mouse model. Res Vet Sci 2012, 93(1):51-56.
18. Yue M., Yang F., Yang J., Bei W., Cai X., Chen L., et al. Complete genome sequence of Haemophilus parasuis SH0165. J Bacteriol 2009, 191(4):1359-1360.
19. Silva A.J., Benitez J.A. Th1-type immune response to a Coccidioides immitis antigen delivered by an attenuated strain of the non-invasive enteropathogen Vibrio cholerae. FEMS Immunol Med Microbiol 2005, 43(3):393-398.
20. Kathaperumal K., Kumanan V., McDonough S., Chen L.H., Park S.U., Moreira M.A., et al. Evaluation of immune responses and protective efficacy in a goat model following immunization with a coctail of recombinant antigens and a polyprotein of Mycobacterium avium subsp. paratuberculosis. Vaccine 2009, 27(1):123-135.
21. Kathaperumal K., Park S.U., McDonough S., Stehman S., Akey B., Huntley J., et al. Vaccination with recombinant Mycobacterium avium subsp. paratuberculosis proteins induces differential immune responses and protects calves against infection by oral challenge. Vaccine 2008, 26(13):1652-1663.
22. Vanier G., Szczotka A., Friedl P., Lacouture S., Jacques M., Gottschalk M. Haemophilus parasuis invades porcine brain microvascular endothelial cells. Microbiology 2006, 152(Pt 1):135-142.
23. Cerdà-Cuéllar M., Aragon V. Serum-resistance in Haemophilus parasuis is associated with systemic disease in swine. Vet J 2008, 175:384-389.
24. Ruiz A., Oliveira S., Torremorell M., Pijoan C. Outer membrane proteins and DNA profiles in strain Haemophilus parasuis recovered from systemic and respiratory sites. J Clin Microbiol 2001, 39(5):1757-1762.
25. Wisselink H.J., Vecht U., Stockhofe-Zurwieden N., Smith H.E. Protection of pigs against challenge with virulent Streptococcus suis serotype Z strains by a muramidase-released protein and extracellular factor vaccine. Vet Rec 2001, 148(15):473-477.
26. Seder R.A., Hill A.V.S. Vaccines against intracellular infections requiring cellular immunity. Nature 2000, 406:793-798.
27. Seder R.A., Darrah P.A., Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat Rev 2008, 8(4):247-258.
28. Huang X., Li Y., Fu Y., Ji Y., Lian K., Zheng H., et al. Cross-protective efficacy of recombinant transferrin-binding protein A of Haemophilus parasuis in guinea pigs. Clin Vaccine Immunol 2013, 20(6):912-919.